YINCHUAN — Ningxia’s Drug Administration has released new processing standards for two traditional Chinese medicinal slices: Da Ji Teng (Paederia foetida L.) and Xia Mai (wheat). The standards, effective immediately, follow a rigorous review process involving expert evaluation and public consultation, ensuring compliance with national pharmaceutical regulations.

Policy Breakdown

• Regulatory Framework: The standards adhere to multiple national guidelines, including the Technical Guidance Principles for Revising Provincial Herbal Slice Processing Standards and the Notification on Filing Procedures for Provincial Herbal Slice Processing Standards.
• Quality Control: The new standards aim to enhance the quality and safety of herbal medicines, crucial for Ningxia’s growing traditional medicine sector.
• Market Implications: The move underscores Ningxia’s commitment to standardizing traditional medicine production, potentially boosting consumer confidence and market expansion.

Industry Impact
Pharmaceutical companies and traditional medicine producers are encouraged to align with the new standards to maintain market access. The regulations also signal opportunities for innovation in herbal medicine processing techniques.

Looking Ahead
Stakeholders should monitor how these standards influence regional and national market dynamics, potentially setting a benchmark for other provinces. The long-term goal is to foster high-quality development in Ningxia’s traditional medicine industry.-China Health Reform Pulse

For detailed implementation guidelines and the full standards, refer to the official announcements from Ningxia’s Drug Administration.

Policy Source: http://nxyjj.nx.gov.cn/yp/ggtg_37855/202505/t20250526_4916829.html